| TOP STORY | Skp2 Activates Cancer-Promoting, Glucose-Processing Akt Scientists report that HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism. They also found that this chain of events promotes Herceptin resistance in breast cancer and activation of glucose metabolism. [Press release from The University of Texas MD Anderson Cancer Center discussing online prepublication in Cell] Press Release | Abstract |
|
|
|